BeOne Medicines Ltd ADR’s recent filing unveils that its Officer JOHN OYLER acquired Company’s shares for reported $0.37 million on Jun 17 ’25. In the deal valued at $256.49 per share,1,460 shares were bought.
Then, LAI WANG bought 470 shares, generating $118,142 in total proceeds.
Before that, XIAOBIN WU bought 630 shares. BeOne Medicines Ltd ADR shares valued at $158,047 were divested by the Officer at a price of $250.87 per share.
RBC Capital Mkts initiated its BeOne Medicines Ltd ADR [ONC] rating to an Outperform in a research note published on April 07, 2025; the price target was $312. A number of analysts have revised their coverage, including BofA Securities’s analysts, who increased its forecast for the stock in early March from “a Neutral” to “a Buy”. JMP Securities started covering the stock on September 18, 2024. It rated ONC as “a Mkt outperform”.
Price Performance Review of ONC
On Tuesday, BeOne Medicines Ltd ADR [NASDAQ:ONC] saw its stock fall -3.91% to $254.09. Over the last five days, the stock has lost -3.54%. BeOne Medicines Ltd ADR shares have risen nearly 37.56% since the year began. Nevertheless, the stocks have risen 52.72% over the past one year. While a 52-week high of $287.88 was reached on 02/27/25, a 52-week low of $141.31 was recorded on 01/08/25.
Levels Of Support And Resistance For ONC Stock
The 24-hour chart illustrates a support level at 249.57, which if violated will result in even more drops to 245.06. On the upside, there is a resistance level at 258.55. A further resistance level may holdings at 263.02.
